Found: 2
Select item for more details and to access through your institution.
Oxaliplatin-Free Interval as a Risk Factor for Hypersensitivity Reaction among Colorectal Cancer Patients Treated with FOLFOX.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 136, doi. 10.1159/000320613
- By:
- Publication type:
- Article
Phase II Study of Concurrent Chemoradiotherapy at the Dose of 50.4 Gy with Elective Nodal Irradiation for Stage II–III Esophageal Carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 6, p. 608, doi. 10.1093/jjco/hyt048
- By:
- Publication type:
- Article